Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.090
+0.180 (6.19%)
At close: Aug 13, 2025, 4:00 PM
3.010
-0.080 (-2.59%)
Pre-market: Aug 14, 2025, 8:41 AM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $333.42 million as of August 14, 2025. Its market cap has decreased by -85.50% in one year.
Market Cap
333.42M
Enterprise Value
87.13M
1-Year Change
-85.50%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $333.42M, an increase of 249.87%. That is a compound annual growth rate of 12.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 314.00M | -72.60% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |